Mehmet Cudi Tuncer

67PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunityPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Aug 27, 2026
Thymoquinone Potentiates Docetaxel-Induced Antitumor Activity with the Involvement of ROS and PI3K/AKT Pathway Modulation in Triple-Negative Breast Cancer Cells.

|Aug 13, 2026
Rosmarinic Acid Sensitizes Ovarian Cancer Cells to Gemcitabine Through Oxidative Stress-Associated Apoptotic and Antiproliferative Responses.

|Aug 13, 2026
Rosmarinic Acid Potentiates Cisplatin-Induced Antitumour Activity Through ROS-Associated Apoptotic Signalling in Two- and Three-Dimensional Breast Cancer Models.

|Jul 28, 2026
Gallic Acid Enhances the Anticancer Activity of Docetaxel in Triple-Negative Breast Cancer Cells.

|Jul 15, 2026
Effects of Rosmarinic Acid and Doxorubicin Combination in Breast Cancer Cells.

|Jun 26, 2026
Gallic Acid Enhances Carboplatin-Induced Antitumoral Responses in Cervical Cancer Cells Through Oxidative Stress-Associated Mitochondrial and Apoptotic Mechanisms.

Pageof 12

Frequent Collaborators

9 joint publications

İlhan Özdemir

5 joint publications

Şamil Öztürk

4 joint publications

Zülfikar Özgür Ertuğrul

4 joint publications

Mehmet Uğur Karabat